{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T15:56:39Z","timestamp":1793462199918,"version":"4.5.0"},"reference-count":75,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>To synthesize current knowledge on the genetic, immunopathogenic, and clinical presentations of systemic sclerosis (SSc) and primary biliary cholangitis (PBC) with a focus on their co-occurrence as a clinically relevant overlap syndrome. This narrative review summarizes preclinical and clinical studies addressing SSc-PBC overlap.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>Genomic studies highlight shared susceptibility loci between SSc and PBC. Furthermore, SSc\u2013PBC overlap patient sera reveals anticentromere antibodies which cross-react with an antigenic motif on pyruvate dehydrogenase-E2 (structural core of pyruvate dehydrogenase complex catalyzing formation of acetyl coA), the most common target of antimitochondrial antibodies in PBC. Similar profibrotic cytokines and T regulatory cell profiles are identified in sera and skin and liver biopsies of patients with SSc and PBC respectively. Analysis of clinical phenotypes reveals that SSc\u2013PBC overlap patients have reduced incidence of pulmonary fibrosis and pulmonary arterial hypertension compared to SSc alone, and less severe hepatic involvement compared to PBC alone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>SSc\u2013PBC overlap remains an understudied disease process. This review summarizes current knowledge and outlines future directions to guide research and improve care for patients with this distinct clinical overlap.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/bor.0000000000001127","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T11:00:55Z","timestamp":1757329255000},"page":"413-421","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["A comprehensive review of systemic sclerosis\u2013primary biliary cholangitis overlap: emerging evidence for a distinct clinical subtype"],"prefix":"10.1097","volume":"37","author":[{"given":"Areeka","family":"Memon","sequence":"first","affiliation":[{"name":"Yale School of Medicine, Department of Internal Medicine, Section of Rheumatology, Allergy, & Immunology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manvitha","family":"Nadella","sequence":"additional","affiliation":[{"name":"Yale School of Medicine, Department of Internal Medicine, Section of Rheumatology, Allergy, & Immunology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Emokpae","sequence":"additional","affiliation":[{"name":"Yale School of Medicine, Department of Internal Medicine, Section of Rheumatology, Allergy, & Immunology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David N.","family":"Assis","sequence":"additional","affiliation":[{"name":"Yale School of Medicine, Department of Internal Medicine, Section of Digestive Diseases, New Haven, Connecticut, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,9,5]]},"reference":[{"key":"R1-20251007","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/art.40377","article-title":"Defining a unified vascular phenotype in systemic sclerosis","volume":"70","author":"Allanore","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"R2-20251007","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/hep.32117","article-title":"Primary biliary cholangitis: 2021 practice guidance update from the American Association for the Study of Liver Diseases","volume":"75","author":"Lindor","year":"2022","journal-title":"Hepatology"},{"key":"R3-20251007","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1055\/s-0039-1697617","article-title":"The pathogenesis of primary biliary cholangitis: a comprehensive review","volume":"40","author":"Lleo","year":"2020","journal-title":"Semin Liver Dis"},{"key":"R4-20251007","doi-asserted-by":"crossref","first-page":"1551911","DOI":"10.3389\/fimmu.2025.1551911","article-title":"A review of recent studies on the pathogenesis of systemic sclerosis: focus on fibrosis pathways","volume":"16","author":"Jimenez","year":"2025","journal-title":"Front Immunol"},{"key":"R5-20251007","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/BOR.0000000000001063","article-title":"A scoping review of the epidemiology of systemic sclerosis and its organ manifestations: 2018\u20132024","volume":"37","author":"Good","year":"2025","journal-title":"Curr Opin Rheumatol"},{"key":"R6-20251007","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1111\/jgh.15329","article-title":"Regional variation and temporal trend of primary biliary cholangitis epidemiology: a systematic review and meta-analysis","volume":"36","author":"Lv","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"key":"R7-20251007","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2025.03.025","article-title":"Global epidemiology of primary biliary cholangitis: an updated systematic review and meta-analysis","author":"Jie-Rae Tan","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R8-20251007","doi-asserted-by":"crossref","first-page":"102321","DOI":"10.1016\/j.clinre.2024.102321","article-title":"Extrahepatic conditions of primary biliary cholangitis: a systematic review and meta-analysis of prevalence and risk","volume":"48","author":"Liang","year":"2024","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"R9-20251007","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s12016-021-08904-y","article-title":"Antimitochondrial antibodies: from bench to bedside","volume":"63","author":"Colapietro","year":"2022","journal-title":"Clin Rev Allergy Immunol"},{"key":"R10-20251007","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1177\/23971983231155948","article-title":"Systemic sclerosis and primary biliary cholangitis: longitudinal data to determine the outcomes","volume":"8","author":"Lepri","year":"2023","journal-title":"J Scleroderma Relat Disord"},{"key":"R11-20251007","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41467-022-34606-w","article-title":"Unique DUOX2(+)ACE2(+) small cholangiocytes are pathogenic targets for primary biliary cholangitis","volume":"14","author":"Li","year":"2023","journal-title":"Nat Commun"},{"key":"R12-20251007","doi-asserted-by":"crossref","article-title":"A biliary HCO3 \u2212 umbrella constitutes a protective mechanism against bile acid\u2013induced injury in human cholangiocytes","author":"Hohenester","DOI":"10.1002\/hep.24691"},{"key":"R13-20251007","doi-asserted-by":"crossref","first-page":"22640","DOI":"10.1038\/s41598-025-07311-z","article-title":"Endothelial cells expressing CPE and vWF are involved in the immunopathogenesis of primary biliary cholangitis","volume":"15","author":"Huang","year":"2025","journal-title":"Scientific Reports"},{"key":"R14-20251007","doi-asserted-by":"crossref","first-page":"103289","DOI":"10.1016\/j.jaut.2024.103289","article-title":"Epidemiologic and genetic associations between primary biliary cholangitis and extrahepatic rheumatic diseases","volume":"148","author":"Qian","year":"2024","journal-title":"J Autoimmun"},{"key":"R15-20251007","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4078\/jrd.2024.0129","article-title":"Pathogenesis of systemic sclerosis: an integrative review of recent advances","volume":"32","author":"Son","year":"2025","journal-title":"J Rheum Dis"},{"key":"R16-20251007","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1196\/annals.1422.059","article-title":"Epstein\u2013Barr virus and cytomegalovirus in autoimmune diseases","volume":"1108","author":"Barzilai","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"R17-20251007","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/hep.20907","article-title":"Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients","volume":"42","author":"Gershwin","year":"2005","journal-title":"Hepatology"},{"key":"R18-20251007","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3748\/wjg.v22.i1.338","article-title":"Xenobiotics and loss of tolerance in primary biliary cholangitis","volume":"22","author":"Wang","year":"2016","journal-title":"World J Gastroenterol"},{"key":"R19-20251007","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1002\/tox.23906","article-title":"Estrogen receptor alpha-mediated mitochondrial damage in intrahepatic bile duct epithelial cells leading to the pathogenesis of primary biliary cholangitis","volume":"38","author":"Liang","year":"2023","journal-title":"Environ Toxicol"},{"key":"R20-20251007","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/hep.32172","article-title":"E. coli and the etiology of human PBC: Antimitochondrial antibodies and spreading determinants","volume":"75","author":"Yang","year":"2022","journal-title":"Hepatology"},{"key":"R21-20251007","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/cei.13198","article-title":"Pathogen infections and primary biliary cholangitis","volume":"195","author":"Tanaka","year":"2019","journal-title":"Clin Exp Immunol"},{"key":"R22-20251007","doi-asserted-by":"crossref","first-page":"19705","DOI":"10.1038\/s41598-021-99314-9","article-title":"Ileal mucosa-associated microbiota overgrowth associated with pathogenesis of primary biliary cholangitis","volume":"11","author":"Kitahata","year":"2021","journal-title":"Sci Rep"},{"key":"R23-20251007","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0140-6736(22)01692-0","article-title":"Systemic sclerosis","volume":"401","author":"Volkmann","year":"2023","journal-title":"Lancet"},{"key":"R24-20251007","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/cei.13588","article-title":"Investigation of immune complexes formed by mitochondrial antigens containing a new lipoylated site in sera of primary biliary cholangitis patients","volume":"204","author":"Aibara","year":"2021","journal-title":"Clin Exp Immunol"},{"key":"R25-20251007","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0140-6736(24)01303-5","article-title":"Primary biliary cholangitis","volume":"404","author":"Tanaka","year":"2024","journal-title":"Lancet"},{"key":"R26-20251007","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.cld.2023.07.002","article-title":"Autoimmune markers in primary biliary cholangitis","volume":"28","author":"Shah","year":"2024","journal-title":"Clin Liver Dis"},{"key":"R27-20251007","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/art.43081","article-title":"Cross-phenotype genome-wide association study on the shared genetic susceptibility to systemic sclerosis and primary biliary cholangitis","volume":"77","author":"Luo","year":"2025","journal-title":"Arthritis Rheumatol"},{"key":"R28-20251007","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/s12876-024-03319-3","article-title":"Primary biliary cholangitis has causal effects on systemic rheumatic diseases: a Mendelian randomization study","volume":"24","author":"Zhang","year":"2024","journal-title":"BMC Gastroenterol"},{"key":"R29-20251007","doi-asserted-by":"crossref","first-page":"930970","DOI":"10.3389\/fimmu.2022.930970","article-title":"Can antinuclear antibodies have a pathogenic role in systemic sclerosis?","volume":"13","author":"Chepy","year":"2022","journal-title":"Front Immunol"},{"key":"R30-20251007","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/cei\/uxad012","article-title":"Systemic sclerosis and primary biliary cholangitis share an antibody population with identical specificity","volume":"212","author":"Favoino","year":"2023","journal-title":"Clin Exp Immunol"},{"key":"R31-20251007","doi-asserted-by":"crossref","first-page":"14438","DOI":"10.3390\/ijms241914438","article-title":"Enhanced innate and acquired immune responses in systemic sclerosis primary peripheral blood mononuclear cells (PBMCs)","volume":"24","author":"Szabo","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R32-20251007","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3390\/ijms26020605","article-title":"Soluble herpes virus entry mediator and type II\/III interferons are upregulated in primary biliary cholangitis","volume":"26","author":"Chung","year":"2025","journal-title":"Int J Mol Sci"},{"key":"R33-20251007","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/hepr.12285","article-title":"Pathophysiology and recent findings of primary biliary cirrhosis complicated by systemic sclerosis","volume":"44","author":"Ohira","year":"2014","journal-title":"Hepatol Res"},{"key":"R34-20251007","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.autrev.2012.05.004","article-title":"Th17 and regulatory T lymphocytes in primary biliary cirrhosis and systemic sclerosis as models of autoimmune fibrotic diseases","volume":"12","author":"Fenoglio","year":"2012","journal-title":"Autoimmun Rev"},{"key":"R35-20251007","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jaut.2008.11.001","article-title":"Hepatic IL-17 responses in human and murine primary biliary cirrhosis","volume":"32","author":"Lan","year":"2009","journal-title":"J Autoimmun"},{"key":"R36-20251007","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1007\/s00296-011-2056-y","article-title":"Th17 peripheral cells are increased in diffuse cutaneous systemic sclerosis compared with limited illness: a cross-sectional study","volume":"32","author":"Rodr\u00edguez-Reyna","year":"2012","journal-title":"Rheumatol Int"},{"key":"R37-20251007","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.clim.2011.01.013","article-title":"Alteration of Th17 and Treg cell subpopulations co-exist in patients affected with systemic sclerosis","volume":"139","author":"Fenoglio","year":"2011","journal-title":"Clin Immunol"},{"key":"R38-20251007","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jaut.2010.06.004","article-title":"Phenotypical and functional alterations of CD8 regulatory T cells in primary biliary cirrhosis","volume":"35","author":"Bernuzzi","year":"2010","journal-title":"J Autoimmun"},{"key":"R39-20251007","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/2397198318823122","article-title":"History of skin thickness assessment and the Rodnan skin thickness scoring method in systemic sclerosis","volume":"4","author":"Medsger","year":"2019","journal-title":"J Scleroderma Related Disord"},{"key":"R40-20251007","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1572-0241.2006.00423.x","article-title":"Dermatological manifestations in primary biliary cirrhosis patients: a case control study","volume":"101","author":"Koulentaki","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"R41-20251007","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1007\/s10067-020-05549-8","article-title":"Prevalence and predictors of small intestinal bacterial overgrowth in systemic sclerosis: a systematic review and meta-analysis","volume":"40","author":"Feng","year":"2021","journal-title":"Clin Rheumatol"},{"key":"R42-20251007","doi-asserted-by":"crossref","first-page":"e13691","DOI":"10.1111\/nmo.13691","article-title":"High occurrence of small intestinal bacterial overgrowth in primary biliary cholangitis","volume":"31","author":"Liu Chen Kiow","year":"2019","journal-title":"Neurogastroenterol Motil"},{"key":"R43-20251007","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.jhep.2024.07.014","article-title":"Fatigue is a symptom of clinical importance in patients with primary sclerosing cholangitis (SOMA.LIV)","volume":"82","author":"Hartl","year":"2025","journal-title":"J Hepatol"},{"key":"R44-20251007","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1093\/rheumatology\/kes206","article-title":"Measuring fatigue in SSc: a comparison of the Short Form-36 Vitality subscale and Functional Assessment of Chronic Illness Therapy-Fatigue scale","volume":"51","author":"Harel","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"R45-20251007","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.4254\/wjh.v14.i6.1111","article-title":"Understanding fatigue in primary biliary cholangitis: from pathophysiology to treatment perspectives","volume":"14","author":"Lynch","year":"2022","journal-title":"World J Hepatol"},{"key":"R46-20251007","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.amjms.2022.12.005","article-title":"PACK syndrome: a case series and review","volume":"365","author":"Collins","year":"2023","journal-title":"Am J Med Sci"},{"key":"R47-20251007","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/gut.2005.075002","article-title":"Clinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis","volume":"55","author":"Rigamonti","year":"2006","journal-title":"Gut"},{"key":"R48-20251007","doi-asserted-by":"crossref","first-page":"976427","DOI":"10.1155\/2011\/976427","article-title":"Primary biliary cirrhosis associated with systemic sclerosis: diagnostic and clinical challenges","volume":"2011","author":"Rigamonti","year":"2011","journal-title":"Int J Rheumatol"},{"key":"R49-20251007","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1346-8138.1999.tb03503.x","article-title":"Clinical and immunological characterization of patients with systemic sclerosis overlapping primary biliary cirrhosis: a comparison with patients with systemic sclerosis alone","volume":"26","author":"Akimoto","year":"1999","journal-title":"J Dermatol"},{"key":"R50-20251007","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1007\/s00296-011-1963-2","article-title":"Evaluation of liver function tests in scleroderma patients","volume":"32","author":"Salem","year":"2012","journal-title":"Rheumatol Int"},{"key":"R51-20251007","doi-asserted-by":"crossref","first-page":"966","DOI":"10.3390\/jcm11040966","article-title":"Clinical relevance of liver involvement in the clinical course of systemic sclerosis","volume":"11","author":"Lorena","year":"2022","journal-title":"J Clin Med"},{"key":"R52-20251007","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.semarthrit.2017.10.004","article-title":"Hepatobiliary involvement in systemic sclerosis and the cutaneous subsets: characteristics and survival of patients from the Spanish RESCLE Registry","volume":"47","author":"Mar\u00ed-Alfonso","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"R53-20251007","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3899\/jrheum.160243","article-title":"Prevalence of systemic sclerosis in primary biliary cholangitis using the new ACR\/EULAR classification criteria","volume":"44","author":"Zheng","year":"2017","journal-title":"J Rheumatol"},{"key":"R54-20251007","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.dld.2024.05.002","article-title":"Position paper of the Italian Association for the Study of the Liver (AISF): management and treatment of primary biliary cholangitis","volume":"56","year":"2024","journal-title":"Dig Liver Dis"},{"key":"R55-20251007","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"65","author":"van den Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"key":"R56-20251007","doi-asserted-by":"crossref","first-page":"E129","DOI":"10.1111\/hepr.12255","article-title":"Evaluation of nail fold capillaroscopy findings in patients with primary biliary cirrhosis","volume":"44","author":"Monoe","year":"2014","journal-title":"Hepatol Res"},{"key":"R57-20251007","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/jgh.15214","article-title":"Extrahepatic autoimmune diseases in primary biliary cholangitis: prevalence and significance for clinical presentation and disease outcome","volume":"36","author":"Efe","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"key":"R58-20251007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/5557814","article-title":"Clinical characteristics and prognosis of concomitant primary biliary cholangitis and autoimmune diseases: a retrospective study","volume":"2021","author":"Liu","year":"2021","journal-title":"Can J Gastroenterol Hepatol"},{"key":"R59-20251007","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.clinre.2013.04.005","article-title":"Diagnostic and clinical significance of anticentromere antibodies in primary biliary cirrhosis","volume":"37","author":"Liberal","year":"2013","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"R60-20251007","first-page":"1517","article-title":"Systemic sclerosis: one year in review 2024","volume":"42","author":"Lepri","year":"2024","journal-title":"Clin Exp Rheumatol"},{"key":"R61-20251007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jim.2017.10.001","article-title":"Detection of antimitochondrial antibodies by immunoprecipitation in patients with systemic sclerosis","volume":"452","author":"Ceribelli","year":"2018","journal-title":"J Immunol Methods"},{"key":"R62-20251007","doi-asserted-by":"crossref","first-page":"e101916","DOI":"10.1371\/journal.pone.0101916","article-title":"Meta-analysis assessment of GP210 and SP100 for the diagnosis of primary biliary cirrhosis","volume":"9","author":"Hu","year":"2014","journal-title":"PLoS One"},{"key":"R63-20251007","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.3899\/jrheum.090340","article-title":"Primary biliary cirrhosis (PBC), PBC autoantibodies, and hepatic parameter abnormalities in a large population of systemic sclerosis patients","volume":"36","author":"Assassi","year":"2009","journal-title":"J Rheumatol"},{"key":"R64-20251007","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41584-023-00909-5","article-title":"State-of-the-art evidence in the treatment of systemic sclerosis","volume":"19","author":"Pope","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"R65-20251007","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.cgh.2017.09.062","article-title":"Twenty-year comparative analysis of patients with autoimmune liver diseases on transplant waitlists","volume":"16","author":"Webb","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R66-20251007","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.dld.2022.12.010","article-title":"Treatment response to ursodeoxycholic acid in primary biliary cholangitis: a systematic review and meta-analysis","volume":"55","author":"Gazda","year":"2023","journal-title":"Dig Liver Dis"},{"key":"R67-20251007","doi-asserted-by":"crossref","first-page":"e0612","DOI":"10.1097\/HC9.0000000000000612","article-title":"PPAR agonists for the treatment of cholestatic liver diseases: over a decade of clinical progress","volume":"9","author":"Hayes","year":"2025","journal-title":"Hepatol Commun"},{"key":"R68-20251007","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.3390\/jpm14121133","article-title":"Up-to-date snapshot of current and emerging medical therapies in primary biliary cholangitis","volume":"14","author":"Warsop","year":"2024","journal-title":"J Pers Med"},{"key":"R69-20251007","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1111\/liv.14871","article-title":"Safety of fibrates in cholestatic liver diseases","volume":"41","author":"Carrion","year":"2021","journal-title":"Liver Int"},{"key":"R70-20251007","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/hep.27744","article-title":"Fibrates and cholestasis","volume":"62","author":"Ghonem","year":"2015","journal-title":"Hepatology"},{"key":"R71-20251007","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1056\/NEJMoa2312100","article-title":"A phase 3 trial of seladelpar in primary biliary cholangitis","volume":"390","author":"Hirschfield","year":"2024","journal-title":"N Engl J Med"},{"key":"R72-20251007","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1124\/jpet.121.000695","article-title":"Bosentan alters endo- and exogenous bile salt disposition in sandwich-cultured human hepatocytes","volume":"379","author":"Oorts","year":"2021","journal-title":"J Pharmacol Exp Ther"},{"key":"R73-20251007","doi-asserted-by":"crossref","first-page":"1475528","DOI":"10.3389\/fimmu.2024.1475528","article-title":"Gut microbiome and metabolomics in systemic sclerosis: feature, link and mechanisms","volume":"15","author":"Yao","year":"2024","journal-title":"Front Immunol"},{"key":"R74-20251007","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1053\/j.gastro.2024.05.014","article-title":"Gut microbiota-derived butyrate induces epigenetic and metabolic reprogramming in myeloid-derived suppressor cells to alleviate primary biliary cholangitis","volume":"167","author":"Wang","year":"2024","journal-title":"Gastroenterology"},{"key":"R75-20251007","doi-asserted-by":"crossref","first-page":"28301","DOI":"10.1038\/s41598-024-79227-z","article-title":"Bidirectional Mendelian randomization links gut microbiota to primary biliary cholangitis","volume":"14","author":"Zhou","year":"2024","journal-title":"Scientific Reports"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000001127","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T05:01:03Z","timestamp":1759813263000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000001127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,5]]},"references-count":75,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000001127","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,5]]}}}